Can Rituximab Change the Usually Dismal Prognosis of Patients With Intravascular Large B-Cell Lymphoma?-Reference-Cited by-同舟云学术

Can Rituximab Change the Usually Dismal Prognosis of Patients With Intravascular Large B-Cell Lymphoma?

Published:2008-11-01 Issue:31 Volume:26 Page:5134-5136
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ferreri Andrés J.M.¹,Dognini Giuseppina P.¹,Govi Silvia¹,Crocchiolo Roberto¹,Bouzani Maria²,Bollinger Claudia R.³,D'Incan Michel⁴,Delaporte Emmanuel⁵,Hamadani Mehdi⁶,Jardin Fabrice⁷,Martusewicz-Boros Magdalena⁸,Montanari Mauro⁹,Szomor Arpad¹⁰,Zucca Emanuele¹¹,Cavalli Franco¹¹,Ponzoni Maurilio¹²

Affiliation:

1. Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy; International Extranodal Lymphoma Study Group, Bellinzona, Switzerland

2. Department of Hematology and Lymphoma, Evangelismos Hospital, Athens, Greece

3. University Hospital of Essen, Essen, Germany

4. Centre Hospitalier Universitaire Hôtel-Dieu, Clermont-Ferrand, France

5. Centre Hospitalier Universitaire Lille, Lille, France

6. The Ohio State University, Columbus, OH

7. Centre Henri Becquerel, Rouen, France

8. National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

9. Clinica di Ematologia, Azienda Ospedali Riuniti di Ancona, Ancona, Italy

10. First Department of Medicine, University of Pecs, Pecs, Hungary

11. International Extranodal Lymphoma Study Group, Bellinzona, Switzerland; Division of Medical Oncology, Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland

12. Unit of Lymphoid Malignancies and Pathology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy; International Extranodal Lymphoma Study Group, Bellinzona, Switzerland

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.19.1841

Reference8 articles.

1. Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy As Reported by the IVL Study Group in Japan

2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

3. Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting

4. An Asian Variant of Intravascular Lymphomatosis: An Updated Review of Malignant Histiocytosis-Like B-Cell Lymphoma

5. Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell Lymphoma;American Journal of Surgical Pathology;2024-03-18

2. Haemophagocytic lymphohistiocytosis and intravascular large B-cell lymphoma: hidden partners in crime;Pathology;2023-12

3. Clinical Spectrum, Diagnosis, and Treatment Outcome in Individuals With Intravascular Large B-cell Lymphoma Affecting the Nervous System: A Case Series;Cureus;2023-04-01

4. Ocular Involvement in a Patient with Intravascular Large B-Cell Lymphoma: A Diagnostic Challenge. Clinical Case Report and Literature Review;Ocular Immunology and Inflammation;2023-02-06

5. A Rare Case of Intravascular Large B-cell Lymphoma Presenting With Bilateral Ophthalmoplegia, Along With a Literature Review;Cureus;2022-06-14